Alastair (Alex) Rampell
General Partner
Andreessen Horowitz
a16z GP leading Apps, with fintech and marketplace investments and multiple founder exits.
Bio
Professional summary
Jorge Conde is a General Partner on the Bio + Health team at Andreessen Horowitz. His official profile states that he focuses on life sciences and healthcare investments across therapeutics, diagnostics, tools, and software. The profile lists current board roles at Asimov, Cartography, Dyno, Earli, Komodo Health, and Octant Bio. Public company material also describes him as investing at the intersection of biology, computer science, and engineering.
Investment focus
Stage, sector, and overall fit
Stage
Bio and health venture investmentsTherapeutics, diagnostics, tools, and software companies
Sector
Life sciencesHealthcareTherapeuticsDiagnosticsBio tools and software
Thesis
Life sciences and healthcareTherapeutics, diagnostics, tools, and softwareBiology, computer science, and engineering intersection
Notable companies
Selected portfolio companies the partner has backed
AsimovCartographyDynoEarliKomodo HealthOctant BioThird Arc Bio
How to approach
Framing and angles for outreach
Pitch framing
Lead with the scientific or clinical thesis, the translational path, and why software, tools, diagnostics, or therapeutics can create a durable health platform.
Personalization hooks
- 1Connect the pitch to life sciences and healthcare, especially where biology intersects with software or engineering.
- 2For therapeutics or diagnostics, emphasize clinical validation, biology rationale, and platform extensibility.
Recent signals
What the partner has said or done recently
Public company announcement says a16z joined a Third Arc Bio financing and Jorge Conde joined its board.
Background
Career, education, and skills
Career history
- Andreessen Horowitz (a16z)General Partner, Bio + HealthPresent
- Syros PharmaceuticalsChief Strategy Officer / CFO / Chief Product OfficerPrior to a16z
- Knome (acquired by Tute Genomics, 2015)Co-Founder & CEOPrior
- MedImmuneMarketing & OperationsPrior
- Morgan StanleyBiotechnology Investment BankerPrior
Education
- Harvard Business SchoolMBA
- Harvard-MIT Division of Health Sciences and TechnologyMS
- Johns Hopkins UniversityBA, Biology
Skills
Life sciences investingGenomicsTherapeuticsHealthcare strategyBiotech investment banking
Other partners at Andreessen Horowitz
12 more profiles
Alex Immerman
General Partner
Andreessen Horowitz
a16z Growth GP investing across AI, consumer, B2B, crypto, fintech, and physical-world companies.
Ali Yahya
General Partner
Andreessen Horowitz
a16z crypto GP investing in blockchain infrastructure and decentralized networks.
Amy Hoemeke
Partner
Andreessen Horowitz
Bio + Health operations partner focused on investment and marketing operations.
Andrew Chen
General Partner
Andreessen Horowitz
General Partner at Andreessen Horowitz focused on tech, entertainment, and AI through a16z Speedrun.
Andrew Lee
Partner
Andreessen Horowitz
a16z speedrun partner backing early consumer, AI, and tech startups.
Andrew O.
Partner, Head of Fund Strategy
Andreessen Horowitz
Head of Fund Strategy at a16z, with capital markets and investment banking experience.
Andy McCall
General Partner
Andreessen Horowitz
a16z GP across American Dynamism and AI Apps with Meraki and Samsara go-to-market experience.
Angela Strange
General Partner
Andreessen Horowitz
General Partner at Andreessen Horowitz focused on AI applications, fintech, and insurance.
Anish Acharya
General Partner
Andreessen Horowitz
a16z general partner investing in consumer AI, fintech, and B2C technology.
AA
Anthony Albanese
Managing Partner and Chief Operating Officer, a16z crypto
Andreessen Horowitz
COO of a16z crypto and former NYSE chief regulatory officer.
Audrey Spitzer
Content Project Manager
Andreessen Horowitz
Content project manager supporting Early Stage Venture programs at a16z.